iFabric Corp. Renews License Agreement with TUMI for Antimicrobial Technology Integration

Reuters
Sep 22
<a href="https://laohu8.com/S/IFABF">iFabric Corp.</a> Renews License Agreement with TUMI for Antimicrobial Technology Integration

iFabric Corp. has announced the renewal of its license agreement with TUMI, Inc. The agreement allows TUMI to continue integrating Intelligent Fabric Technologies (North America) Inc.'s PROTX2® antimicrobial solutions in selected products. This renewal, extending the initial agreement made on May 5, 2021, will last for an additional five years. The PROTX2 technology will be included in the linings of TUMI's 19 Degree Polycarbonate carry-on and related items, as well as in linings and select body fabrics for various travel accessories. Both companies expressed their commitment to delivering high-performance, durable, and protective travel solutions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iFabric Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1076636) on September 22, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10